This guideline is a prerequisite for the quality management in the treatment of non-Hodgkin-lymphomas using radioimmunotherapy...
Keywords: Radioimmuntherapie, Non-Hodgkin-Lymphom, CD20-Rezeptoren, Zevalin, Yttrium-90
01/2004 | Nuklearmedizin, Schattauer